SAM
IRWD icon

Smartleaf Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Smartleaf Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3 Hold
1
– – ﹤0.01% 3499
2025
Q4 		$3 Buy
+1
New +$3 ﹤0.01% 3483
2025
Q2 		– Sell
-2,652
Closed -$3.74K – 2855
2025
Q1 		$3.74K Buy
2,652
+1,473
+125% +$3.51K ﹤0.01% 2284
2024
Q4 		$5.16K Buy
1,179
+150
+15% +$609 ﹤0.01% 2236
2024
Q3 		$4.14K Buy
1,029
+706
+219% +$3.8K ﹤0.01% 2206
2024
Q2 		$2K Buy
323
+282
+688% +$2K ﹤0.01% 2224
2024
Q1 		$353 Buy
+41
New +$498 ﹤0.01% 1793

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Smartleaf Asset Management's IRWD Position: Q1 2026 in Review

Smartleaf Asset Management held its Ironwood Pharmaceuticals (IRWD) position steady in Q1 2026 at 1 share worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #3499.

Smartleaf Asset Management first reported a position in IRWD in Q1 2024 and has held it in 7 quarters since. The position peaked at $5.16K in Q4 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Smartleaf Asset Management held 1 share of Ironwood Pharmaceuticals worth $3 as of Q1 2026.
  • Smartleaf Asset Management left its Ironwood Pharmaceuticals share count unchanged in Q1 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #3499 holding.
  • Smartleaf Asset Management first reported a position in Ironwood Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
  • Smartleaf Asset Management's Ironwood Pharmaceuticals position peaked at $5.16K in Q4 2024.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.